= 1.81 Inventors with similar research interests:
Location History:
- Woilheim, DE (1995)
- Weiheim, DE (2004)
- Weilhelm, DE (2010)
- Wielheim, DE (2020)
- Weilheim, DE (1986 - 2022)
Company Filing History:
23 out of 1,648 
22 out of 1,164 
12 out of 621 
Years Active: 1986-2022
Title: Herbert von der Eltz: Innovator in Genomic Probes and Heart Failure Assessment
Introduction
Herbert von der Eltz is a distinguished inventor based in Weilheim, Germany, known for his significant contributions to the field of biotechnology. With an impressive portfolio of 61 patents, he has made strides in innovations related to oligonucleotide probes and methods for assessing heart failure through novel biomarkers.
Latest Patents
Among his latest patents, Herbert has developed a set of single-stranded oligonucleotide probes, which are designed to target specific genomic sequences. This patent not only illustrates his expertise in genomic research but also encompasses a method for detecting relevant genomic target sequences using these probes. Additionally, he has introduced a kit that includes these probes alongside other essential components for effective analysis.
Another pivotal patent addresses the use of IGFBP-7, a marker for heart failure assessment. This invention outlines a method involving the measurement of IGFBP-7 concentrations within samples, potentially combined with other heart failure markers, to evaluate the severity of the condition. The method represents a valuable advancement in clinical diagnostics, enabling better patient outcomes through early detection.
Career Highlights
Herbert's professional journey includes impactful roles at reputable companies such as Boehringer Mannheim GmbH and Roche Diagnostics Operations, Inc. His work at these organizations has significantly contributed to advancements in medical diagnostics and therapeutic innovations, showcasing his commitment to enhancing healthcare.
Collaborations
Throughout his career, Herbert has collaborated with notable colleagues, including Frank Bergmann and Frank Seela. These partnerships have fostered an environment of creativity and innovation, resulting in groundbreaking solutions in the medical field.
Conclusion
Herbert von der Eltz stands out as a leading inventor whose work in the development of oligonucleotide probes and heart failure assessment methods highlights the importance of innovation in biotechnology. His patents not only advance scientific understanding but also pave the way for improved diagnostic tools, ultimately benefiting patient care in the healthcare industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.